GovLens is in free beta — full access while we build. Join the beta →
← 🇩🇪 Bundestag/SCHRIFTLICHE FRAGEdip-323902

Informationsweitergabe des PEI an die EMA bzgl. Limitierungen bei der COVID-19-Impfstoff-Sicherheitsbewertung in Deutschland

Stage otherUpdated 4mo ago
View source ↗

This procedure concerns the sharing of information between the Paul-Ehrlich-Institut (PEI) and the European Medicines Agency (EMA) regarding limitations in assessing the safety of COVID-19 vaccines in Germany. It addresses potential issues in vaccine safety monitoring and reporting, affecting public health and trust in vaccination programs.